Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
2.760
-0.090 (-3.16%)
At close: Nov 22, 2024, 4:00 PM
2.790
+0.030 (1.09%)
After-hours: Nov 22, 2024, 7:07 PM EST
Celularity Employees
Celularity had 120 employees as of December 31, 2023. The number of employees decreased by 105 or -46.67% compared to the previous year.
Employees
120
Change (1Y)
-105
Growth (1Y)
-46.67%
Revenue / Employee
$355,750
Profits / Employee
-$940,250
Market Cap
60.73M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 120 | -105 | -46.67% |
| Dec 31, 2022 | 225 | 0 | - |
| Dec 31, 2021 | 225 | 63 | 38.89% |
| Dec 31, 2020 | 162 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 270 |
| Atara Biotherapeutics | 225 |
| Vicarious Surgical | 131 |
| X4 Pharmaceuticals | 93 |
| electroCore | 68 |
| Immuneering | 68 |
| Spero Therapeutics | 46 |
| Modular Medical | 40 |
CELU News
- 2 days ago - Celularity's Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific - GlobeNewsWire
- 4 days ago - Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter - GlobeNewsWire
- 4 weeks ago - Celularity Files Appeal Request and Amended Compliance Plan with Nasdaq Hearings Panel - GlobeNewsWire
- 5 weeks ago - Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal - GlobeNewsWire
- 5 weeks ago - Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc. - GlobeNewsWire
- 2 months ago - Celularity to Present at H.C. Wainwright's 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Celularity Appoints Richard J. Berman to its Board of Directors - GlobeNewsWire
- 3 months ago - Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing - GlobeNewsWire